Susquehanna International Group
PHIO icon

Susquehanna International Group’s Phio Pharmaceuticals PHIO Stock Holding History

Susquehanna International Group’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-107
Closed -$12K – 13733
2021
Q4 		$12K Sell
107
-73
-41% -$11.6K ﹤0.01% 12910
2021
Q3 		$39K Sell
180
-105
-37% -$21.9K ﹤0.01% 12425
2021
Q2 		$70K Sell
285
-59
-17% -$14.5K ﹤0.01% 12221
2021
Q1 		$99K Buy
+344
New +$114K ﹤0.01% 11867

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's PHIO Position: Q1 2026 in Review

Susquehanna International Group sold out of Phio Pharmaceuticals (PHIO) in Q1 2026, closing a stake of 20,091 shares — an estimated $21.1K sold.

Susquehanna International Group first reported a position in PHIO in Q4 2017 and held it in 7 quarters. The position peaked at $45K in Q2 2019. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Susquehanna International Group reported no remaining Phio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 20,091 Phio Pharmaceuticals shares in Q1 2026, an estimated $21.1K.
  • Susquehanna International Group first reported a position in Phio Pharmaceuticals in Q4 2017 and held it in 7 quarters.
  • Susquehanna International Group's Phio Pharmaceuticals position peaked at $45K in Q2 2019.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.